Blood Level Omega-3 Fatty Acids as Risk Determinant Molecular Biomarker for Prostate Cancer

Table 3

Blood level omega-3 Polyunsaturated fatty acids versus advanced prostate risk random effect analysis model.

Groups		Heterogeneity				Effect estimates and 95% confidence interval				Publication bias
Omega-3 derivatives	Number of study	𝑄 value	df	𝑃 value	𝐼^2	Point estimates	Lower limit	Upper limit	𝑃 value	Begg	Egger
ALA	3	0.654	2	0.721	0.000	0.965	0.576	1.618	0.893	0.296	0.051
DHA	4	2.289	3	0.515	0.000	0.896	0.640	1.256	0.524	1.000	0.342
DPA	3	0.367	2	0.832	0.000	0.870	0.514	1.473	0.606	1.000	0.618
EPA	4	6.180	3	0.103	41.457	0.975	0.582	1.634	0.925	0.308	0.309
(DHA + DPA + EPA)*		8.870	10	0.545	0.000	0.908	0.708	1.164	0.447
(DHA + EPA)*		8.482	7	0.292	17.471	0.919	0.693	1.219	0.559
Total omega-3*		9.580	13	0.728	0.000	0.919	0.734	1.149	0.457

*Generated from total effect estimates from each n-3 PUFA random effect analysis.